Oral mucositis risk with EGFR tyrosine kinase inhibitor monotherapies and combination regimens in...

TL;DR

Summary:
- This article provides a comprehensive overview of the role of the complement system in the pathogenesis of autoimmune diseases, specifically focusing on how dysregulation contributes to tissue damage.
- It explores therapeutic strategies targeting complement activation pathways, highlighting the potential for novel, precision-medicine interventions in managing chronic inflammatory conditions.

Like summarized versions? Support us on Patreon!